274 related articles for article (PubMed ID: 21734072)
1. Insulinoma-released exosomes or microparticles are immunostimulatory and can activate autoreactive T cells spontaneously developed in nonobese diabetic mice.
Sheng H; Hassanali S; Nugent C; Wen L; Hamilton-Williams E; Dias P; Dai YD
J Immunol; 2011 Aug; 187(4):1591-600. PubMed ID: 21734072
[TBL] [Abstract][Full Text] [Related]
2. Insulinoma-released exosomes activate autoreactive marginal zone-like B cells that expand endogenously in prediabetic NOD mice.
Bashratyan R; Sheng H; Regn D; Rahman MJ; Dai YD
Eur J Immunol; 2013 Oct; 43(10):2588-97. PubMed ID: 23817982
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune Responses to Exosomes and Candidate Antigens Contribute to Type 1 Diabetes in Non-Obese Diabetic Mice.
Dai YD; Sheng H; Dias P; Jubayer Rahman M; Bashratyan R; Regn D; Marquardt K
Curr Diab Rep; 2017 Oct; 17(12):130. PubMed ID: 29080983
[TBL] [Abstract][Full Text] [Related]
4. Exosomes released by islet-derived mesenchymal stem cells trigger autoimmune responses in NOD mice.
Rahman MJ; Regn D; Bashratyan R; Dai YD
Diabetes; 2014 Mar; 63(3):1008-20. PubMed ID: 24170696
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic duodenal homeobox 1 protein is a novel beta-cell-specific autoantigen for type I diabetes.
Li SW; Koya V; Li Y; Donelan W; Lin P; Reeves WH; Yang LJ
Lab Invest; 2010 Jan; 90(1):31-9. PubMed ID: 19901909
[TBL] [Abstract][Full Text] [Related]
6. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
[TBL] [Abstract][Full Text] [Related]
7. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
[TBL] [Abstract][Full Text] [Related]
9. Paralytic autoimmune myositis develops in nonobese diabetic mice made Th1 cytokine-deficient by expression of an IFN-gamma receptor beta-chain transgene.
Serreze DV; Pierce MA; Post CM; Chapman HD; Savage H; Bronson RT; Rothman PB; Cox GA
J Immunol; 2003 Mar; 170(5):2742-9. PubMed ID: 12594305
[TBL] [Abstract][Full Text] [Related]
10. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
[TBL] [Abstract][Full Text] [Related]
11. Type 1 diabetes pathogenesis is modulated by spontaneous autoimmune responses to endogenous retrovirus antigens in NOD mice.
Bashratyan R; Regn D; Rahman MJ; Marquardt K; Fink E; Hu WY; Elder JH; Binley J; Sherman LA; Dai YD
Eur J Immunol; 2017 Mar; 47(3):575-584. PubMed ID: 28083937
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic cell mass from autoimmune destruction in the nonobese diabetic mouse model.
Marzo N; Ortega S; Stratmann T; García A; Ríos M; Giménez A; Gomis R; Mora C
J Immunol; 2008 Jan; 180(2):1189-98. PubMed ID: 18178859
[TBL] [Abstract][Full Text] [Related]
13. First signature of islet beta-cell-derived naturally processed peptides selected by diabetogenic class II MHC molecules.
Suri A; Walters JJ; Rohrs HW; Gross ML; Unanue ER
J Immunol; 2008 Mar; 180(6):3849-56. PubMed ID: 18322192
[TBL] [Abstract][Full Text] [Related]
14. Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.
Serreze DV; Chapman HD; Post CM; Johnson EA; Suarez-Pinzon WL; Rabinovitch A
J Immunol; 2001 Jan; 166(2):1352-9. PubMed ID: 11145720
[TBL] [Abstract][Full Text] [Related]
15. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
Chosich N; Harrison LC
Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
[TBL] [Abstract][Full Text] [Related]
16. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice.
Bao M; Yang Y; Jun HS; Yoon JW
J Immunol; 2002 May; 168(10):5369-75. PubMed ID: 11994496
[TBL] [Abstract][Full Text] [Related]
18. Destruction of conditional insulinoma cell lines in NOD mice: a role for autoimmunity.
Cattan P; Rottembourg D; Cottet S; Tardivel I; Dupraz P; Thorens B; Boitard C; Carel JC
Diabetologia; 2003 Apr; 46(4):504-10. PubMed ID: 12739022
[TBL] [Abstract][Full Text] [Related]
19. Th1 and Th2 pancreatic inflammation differentially affects homing of islet-reactive CD4 cells in nonobese diabetic mice.
Hill NJ; Van Gunst K; Sarvetnick N
J Immunol; 2003 Feb; 170(4):1649-58. PubMed ID: 12574327
[TBL] [Abstract][Full Text] [Related]
20. Type 1 diabetes induction in humanized mice.
Tan S; Li Y; Xia J; Jin CH; Hu Z; Duinkerken G; Li Y; Khosravi Maharlooei M; Chavez E; Nauman G; Danzl N; Nakayama M; Roep BO; Sykes M; Yang YG
Proc Natl Acad Sci U S A; 2017 Oct; 114(41):10954-10959. PubMed ID: 28874533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
